| An araC-controlled bacterialcre expression system to produce DNA minicircle vectors for nuclear and mitochondrial gene therapy BW Bigger, O Tolmachov, JM Collombet, M Fragkos, I Palaszewski, ... Journal of Biological Chemistry 276 (25), 23018-23027, 2001 | 192 | 2001 |
| Functional expression of Rab escort protein 1 following AAV2-mediated gene delivery in the retina of choroideremia mice and human cells ex vivo T Tolmachova, OE Tolmachov, AR Barnard, SR de Silva, DM Lipinski, ... Journal of molecular medicine 91, 825-837, 2013 | 97 | 2013 |
| Development of S/MAR minicircles for enhanced and persistent transgene expression in the mouse liver O Argyros, SP Wong, C Fedonidis, O Tolmachov, SN Waddington, ... Journal of molecular medicine 89, 515-529, 2011 | 83 | 2011 |
| Nuclear‐targeted minicircle to enhance gene transfer with non‐viral vectors in vitro and in vivo L Vaysse, LG Gregory, RP Harbottle, E Perouzel, O Tolmachov, ... The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2006 | 58 | 2006 |
| Designing plasmid vectors O Tolmachov Gene Therapy of Cancer: Methods and Protocols, 117-129, 2009 | 53 | 2009 |
| CHM/REP1 cDNA delivery by lentiviral vectors provides functional expression of the transgene in the retinal pigment epithelium of choroideremia mice T Tolmachova, OE Tolmachov, ST Wavre‐Shapton, D Tracey‐White, ... The journal of gene medicine 14 (3), 158-168, 2012 | 52 | 2012 |
| Development of a self-assembling nuclear targeting vector system based on the tetracycline repressor protein L Vaysse, R Harbottle, B Bigger, A Bergau, O Tolmachov, C Coutelle Journal of Biological Chemistry 279 (7), 5555-5564, 2004 | 51 | 2004 |
| Overexpression of connexin 43 using a retroviral vector improves electrical coupling of skeletal myoblasts with cardiac myocytes in vitro O Tolmachov, YL Ma, M Themis, P Patel, H Spohr, KT MacLeod, ... BMC cardiovascular disorders 6, 1-11, 2006 | 46 | 2006 |
| Remarkable stability of an instability-prone lentiviral vector plasmid in Escherichia coli Stbl3 FA Al-Allaf, OE Tolmachov, LP Zambetti, V Tchetchelnitski, H Mehmet 3 Biotech 3, 61-70, 2013 | 35 | 2013 |
| Silencing of transgene expression: A gene therapy perspective OE Tolmachov, T Subkhankulova, T Tolmachova Gene Therapy - Tools and Potential Applications, 49-68, 2013 | 32 | 2013 |
| Hhex and Cer1 Mediate the Sox17 Pathway for Cardiac Mesoderm Formation in Embryonic Stem Cells Y Liu, R Kaneda, TW Leja, T Subkhankulova, O Tolmachov, G Minchiotti, ... Stem cells 32 (6), 1515-1526, 2014 | 31 | 2014 |
| Building mosaics of therapeutic plasmid gene vectors O E Tolmachov Current gene therapy 11 (6), 466-478, 2011 | 28 | 2011 |
| Introduction of chloramphenicol resistance into the modified mouse mitochondrial genome: cloning of unstable sequences by passage through yeast B Bigger, O Tolmachov, JM Collombet, C Coutelle Analytical Biochemistry 277 (2), 236-242, 2000 | 21 | 2000 |
| Designing lentiviral gene vectors OE Tolmachov, T Tolmachova, FA Al-Allaf Viral Gene Therapy, 263-284, 2011 | 17 | 2011 |
| RecET driven chromosomal gene targeting to generate a RecA deficient Escherichia colistrain for Cre mediated production of minicircle DNA O Tolmachov, I Palaszewski, B Bigger, C Coutelle Bmc Biotechnology 6, 1-12, 2006 | 17 | 2006 |
| Tightly-wound miniknot vectors for gene therapy: a potential improvement over supercoiled minicircle DNA OE Tolmachov Medical hypotheses 74 (4), 702-704, 2010 | 16 | 2010 |
| Methods of Transfection with Messenger RNA Gene Vectors OE Tolmachov, T Tolmachova Gene Therapy - Principles and Challenges, 37-56, 2015 | 15 | 2015 |
| Novel ChIP-seq simulating program with superior versatility: isChIP T Subkhankulova, F Naumenko, OE Tolmachov, YL Orlov Briefings in Bioinformatics 22 (4), bbaa352, 2021 | 12 | 2021 |
| Covalent attachment of multifunctional chimeric terminal proteins to 5′ DNA ends: A potential new strategy for assembly of synthetic therapeutic gene vectors O Tolmachov, C Coutelle Medical hypotheses 68 (2), 328-331, 2007 | 9 | 2007 |
| Self-entanglement of long linear DNA vectors using transient non-B-DNA attachment points: A new concept for improvement of non-viral therapeutic gene delivery OE Tolmachov Medical Hypotheses 78 (5), 632-635, 2012 | 7 | 2012 |
Tanya TolmachovaResearch Fellow, Imperial College LondonVerified email at imperial.ac.uk
